IsoPlexis' Series B Round

IsoPlexis raised a round of funding on August 10, 2017.

Isoplexis is a biotechnology company with interest in highly sensitive, multiplexed single-cell analysis tools for the life sciences. The company's specialties include 'secretomic' analysis (in situ p…

Articles about IsoPlexis' Series B Round: